scispace - formally typeset
S

Seung Il Choi

Researcher at Yonsei University

Publications -  52
Citations -  6679

Seung Il Choi is an academic researcher from Yonsei University. The author has contributed to research in topics: TGFBI & Granular corneal dystrophy. The author has an hindex of 22, co-authored 52 publications receiving 6073 citations. Previous affiliations of Seung Il Choi include New York University & Hallym University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent.

Seung Il Choi, +7 more
- 01 Sep 1998 - 
TL;DR: It is suggested that mitochondrial dysfunction caused by oxidative stress gives rise to neurodegeneration in prion disease.
Journal ArticleDOI

Pathogenesis and treatments of TGFBI corneal dystrophies

Kyung Eun Han, +6 more
- 01 Jan 2016 - 
TL;DR: The current knowledge of TGFBI corneal dystrophies including clinical manifestations, epidemiology, most common and recently reported associated mutations for each disease, and treatment modalities are summarized.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II.

Seung Il Choi, +8 more
- 01 Jul 2009 - 
TL;DR: Results suggest that oxidative damage induced by decreased catalase is involved in GCD II pathogenesis, and antioxidant agents represent a possible treatment strategy.